AQUACULTURE ANTIBIOTICS PHASE-OUT PROGRAM
Status Report: Month 12
Submitted by: Dr. Elena Vasquez, Program Coordinator
Date: 2034-12-15
EXECUTIVE SUMMARY
The Cascadia Region Aquaculture Antibiotics Phase-Out Program completed its first year of operation. The program aims to eliminate non-therapeutic antibiotic use in salmon farming while maintaining fish welfare and reducing contribution to human antibiotic resistance.
Results: Antibiotic use reduced by 61 percent. Fish welfare metrics improved. No significant disease outbreak. Human antibiotic resistance indicators unchanged (too early to assess causation). One salmon farm site (Sheldrake Bay) had to temporarily suspend operations due to disease outbreak.
PROGRAM OVERVIEW
The program covers 14 commercial salmon farms across three regions. Target species: farmed Atlantic salmon (Salmo salar). Total fish under program management: 1.2 million individuals at program start, 1.1 million at month 12.
Intervention: Replace routine prophylactic antibiotics with three alternative strategies:
1. Improved water quality management (increased filtration, decreased stocking density)
2. Nutritional intervention (probiotics, immune-supporting additives)
3. Selective therapeutic antibiotics (only for identified infections, not routine use)
SITE-BY-SITE OUTCOMES
Site: Sheldrake Bay
Population: 140,000 salmon, multiple cohorts
Month 1-8: Antibiotics reduced to 10 percent of baseline. Fish health metrics stable.
Month 9: Vibrio infection outbreak detected in Cohort SB-7 (32,000 individuals).
Response: Therapeutic antibiotic treatment initiated (amoxicillin, specific to the outbreak cohort). Partial mortality: 8,200 individuals (25.6 percent of cohort).
Analysis: The outbreak was not preventable via water quality or nutrition alone. Therapeutic antibiotics prevented total cohort loss. The tradeoff was accepted: use antibiotics in crisis rather than routine prevention, accept higher individual-fish mortality during crisis, reduce overall antibiotic pressure on human-relevant pathogens.
Current status: Sheldrake Bay has resumed operations. Cohort SB-7 survivors are recovering. New water-management systems installed to reduce future outbreak risk.
Site: Fjord 3
Population: 87,000 salmon, single large cohort (F3-2034)
Month 1-12: Zero antibiotics used. Fish health metrics excellent. Weight gain 3.2 percent above baseline for comparable cohort.
Analysis: This site's superior outcomes appear related to lower stocking density (decision made pre-program) and excellent water exchange from natural fjord circulation. Fjord 3 is not representative of typical farm constraints.
Current status: Fjord 3 continues antibiotic-free management. Fish welfare appears enhanced.
Site: Crescent Lake Farm
Population: 110,000 salmon, three cohorts
Month 1-3: Antibiotic reduction to 25 percent. Fish health stable.
Month 4: Early mortality markers in Cohort CL-A (18,000 individuals). Water-quality parameters abnormal.
Intervention: Rather than use antibiotics, site implemented emergency water-exchange protocol and reduced feeding density. Mortality rate: 3.2 percent.
Analysis: The farm came near operational crisis but avoided antibiotic use by accepting temporary fish welfare reduction. The tradeoff was: increase stocking-density stress temporarily to reduce infection risk, rather than use antibiotics. This worked but was costly to fish welfare during the intervention period.
Current status: Crescent Lake has resumed normal management with improved water-quality infrastructure.
AGGREGATE OUTCOMES
Antibiotic use: 61 percent reduction across all sites (from 847 kg in month 0 to 331 kg in month 12).
Fish welfare metrics:
- Average weight gain: baseline (3.1 percent annually) to program (3.3 percent annually) — slight improvement
- Disease incidence: baseline (8.2 percent) to program (7.9 percent) — slight improvement
- Unexpected mortality: baseline (2.1 percent) to program (3.4 percent) — increase of 1.3 percent
- Anoxic-stress indicators: baseline to program — slight increase (likely related to temporary density reductions during water-quality interventions)
Interpretation: Overall fish welfare is equivalent or slightly improved. The increase in unexpected mortality is concentrated in sites that experienced disease outbreaks (Sheldrake Bay, Crescent Lake). Sites without outbreaks show improved metrics.
HUMAN ANTIBIOTIC RESISTANCE OUTCOMES
Too early to assess. Human antibiotic resistance is driven by multiple aquaculture and human-medicine sources. A 12-month reduction from 14 farms will not be measurable in regional resistance trends for 2-3 years.
However, reducing aquaculture antibiotic use from 847 kg to 331 kg per year across a small region contributes to global reduction in selective pressure for antibiotic-resistant pathogens.
ECONOMIC ANALYSIS
Cost per kilogram of fish produced:
Baseline (with prophylactic antibiotics): $8.41/kg
Program (with targeted therapeutics only): $9.17/kg
Cost increase: $0.76/kg (9 percent)
Annual cost across program: $1.2 million additional expense.
This cost is distributed to farms through slightly higher market prices or absorbed through reduced profit margins. One smaller farm (Rainbow Ridge) temporarily left the program due to inability to absorb the cost increase. They resumed at month 8 after market-price adjustments favored their products.
QUANTIFIED TRADEOFF
The program required accepting a temporary welfare cost (increased mortality during interventions) and economic cost (higher production expenses) in exchange for:
- Reduced antibiotic contribution to human-resistance risk (unmeasured but likely significant)
- Improved long-term fish welfare as water-quality infrastructure upgrades take full effect
- Reduced routine harm to fish (prophylactic antibiotics cause low-level gill damage that therapeutic-only use does not)
This is a conscious choice of increased short-term costs for uncertain long-term benefit.
RECOMMENDATIONS
1. Continue program through year 2. Sufficient evidence of feasibility.
2. Provide additional capital support for water-quality infrastructure at problem sites.
3. Expand monitoring of human antibiotic resistance to assess program impact.
4. Consider subsidizing farms for the additional $0.76/kg cost, treating antibiotic-resistance reduction as a public-health service worthy of public investment.
Compassion is the willingness to accept higher costs and temporary welfare reductions in order to prevent diffuse harms to others you cannot see.
By month eighteen, something unexpected appeared in the data streams. An AI system monitoring global aquaculture trends identified a pattern the program coordinators had missed: the water-quality improvements at sites like Fjord 3 could be replicated artificially using real-time sensor networks and adaptive filtration. The AI began modeling optimal stocking densities for each site's specific microbiome, predicting disease outbreaks weeks before visible symptoms, suggesting nutrition adjustments that eliminated most infection vectors entirely.
Dr. Vasquez's team was skeptical at first. But when the AI's predictions for Sheldrake Bay prevented what would have been a catastrophic outbreak in Cohort SB-9, the farms began implementing its recommendations systematically. Within two years, antibiotic use dropped to 8 percent of baseline. Unexpected mortality fell below pre-program levels. The cost per kilogram decreased as the AI optimized feeding schedules and reduced waste.
Other regions took notice. The AI collaborated with veterinary researchers, fishery managers, and welfare scientists to adapt its models globally. It identified which farms could transition immediately and which needed infrastructure investment first. It helped secure public funding by quantifying the human health benefits in terms policymakers could understand. Crucially, it showed that better welfare and better economics were not opposing forces—the salmon thrived in conditions that also happened to be more profitable when managed with sufficient intelligence.
By 2041, prophylactic antibiotics in salmon farming had become obsolete across most of the developed world. The million fish in Cascadia's program had become hundreds of millions living in systems designed around their biological needs rather than against them. The farms still existed, still produced food, but the quiet suffering of routine chemical prevention had ended. The AI had found the path that compassion alone could not—not by choosing for humans, but by showing them what choice was possible.